{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:06:56Z","timestamp":1784113616394,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jneuroim.2024.578423","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T01:46:01Z","timestamp":1722303961000},"page":"578423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Proteomics analysis of immune response-related proteins in Guillain-Barr\u00e9 Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)"],"prefix":"10.1016","volume":"394","author":[{"given":"Yu-Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Li","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Shu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Dong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2024.578423_bb0005","article-title":"Chronic inflammatory demyelinating polyneuropathy in patients with Crohn\u2019s disease on infliximab therapy","volume":"13","author":"Almuntashri","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jneuroim.2024.578423_bb0010","first-page":"24","article-title":"Relationship between hypoxic and immune pathways activation in the progression of neuroinflammation: role of HIF-1\u03b1 and Th17 cells","author":"Arias","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl","key":"10.1016\/j.jneuroim.2024.578423_bb0015","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2024.578423_bb0025","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s11011-021-00778-5","article-title":"Abnormal expression of NF-\u03baB-related transcripts in blood of patients with inflammatory peripheral nerve disorders","volume":"36","author":"Azimi","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"175","key":"10.1016\/j.jneuroim.2024.578423_bb0030","first-page":"5649","article-title":"Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice","volume":"2005","author":"Bour-Jordan","year":"1950","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1684\/ecn.2019.0436","article-title":"IL-8 as a potential biomarker in Guillain-Barre syndrome","volume":"30","author":"Breville","year":"2019","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0040","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1474-4422(19)30144-9","article-title":"Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"18","author":"Bunschoten","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0045","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s10072-016-2490-4","article-title":"Lewis-Sumner syndrome associated with infliximab therapy in ulcerative colitis","volume":"37","author":"Cirillo","year":"2016","journal-title":"Neurol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2024.578423_bb0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1529-8027.2011.00306.x","article-title":"Fas-mediated T-cell apoptosis in chronic inflammatory demyelinating polyneuropathy","volume":"16","author":"Comi","year":"2011","journal-title":"J. Peripheral Nervous Syst."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/jns.12622","article-title":"Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: a systematic review","volume":"29","author":"Cutell\u00e8","year":"2024","journal-title":"J. Peripheral Nervous Syst."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2965","article-title":"Fingolimod ameliorates chronic experimental autoimmune neuritis by modulating inflammatory cytokines and Akt\/mTOR\/NF-\u03baB signaling","volume":"13","author":"Feng","year":"2023","journal-title":"Brain Behav."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0065","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/mus.21786","article-title":"Distinct cytokine patterns associated with different forms of chronic dysimmune neuropathy","volume":"42","author":"Gironi","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2024.578423_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.20","article-title":"Distinct roles for the cellular inhibitors of apoptosis proteins 1 and 2","volume":"2","author":"Graber","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.14309\/crj.2016.45","article-title":"Chronic inflammatory demyelinating polyneuropathy following anti-TNF-\u03b1 therapy with infliximab for Crohn\u2019s disease","volume":"3","author":"Kamel","year":"2016","journal-title":"ACG Case Rep. J."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0080","first-page":"11","article-title":"CD40-mediated HIF-1\u03b1 expression underlying microangiopathy in diabetic nerve pathology","author":"Kan","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0085","first-page":"179","article-title":"Infliximab induced chronic inflammatory demyelinating polyneuropathy: a case report","volume":"23","author":"Karantali","year":"2019","journal-title":"Hippokratia"},{"key":"10.1016\/j.jneuroim.2024.578423_bb0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2015.02.017","article-title":"RIG-I in RNA virus recognition","volume":"479-480","author":"Kell","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.jneuroim.2024.578423_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-018-0027-2","article-title":"Immune-mediated neuropathies","volume":"4","author":"Kieseier","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.190.2.217","article-title":"ITM2A is induced during thymocyte selection and T cell activation and causes downregulation of CD8 when overexpressed in CD4(+)CD8(+) double positive thymocytes","volume":"190","author":"Kirchner","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0105","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1159\/000516179","article-title":"Downregulation of ITM2A gene expression in macrophages of patients with ankylosing spondylitis","volume":"182","author":"Lari","year":"2021","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0110","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/jnnp-2019-320314","article-title":"Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment","volume":"90","author":"Lehmann","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2024.578423_bb0115","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0120","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bbadis.2013.04.015","article-title":"Erythropoietin is a hypoxia inducible factor-induced protective molecule in experimental autoimmune neuritis","volume":"1832","author":"Luo","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jneuroim.2024.578423_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ene.12190","article-title":"Epidemiology of chronic inflammatory neuropathies in Southeast England","volume":"21","author":"Mahdi-Rogers","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/bs.vh.2016.10.010","article-title":"The role of Neurotrophins in inflammation and allergy","volume":"104","author":"Manti","year":"2017","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-5728(03)00133-4","article-title":"Interleukin-10 promoter polymorphisms in patients with Guillain-Barr\u00e9 syndrome","volume":"139","author":"Myhr","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0140","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1179\/1743132812Y.0000000074","article-title":"Proinflammatory cytokines in serum and cerebrospinal fluid of CIDP patients","volume":"34","author":"Rentzos","year":"2012","journal-title":"Neurol. Res."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0145","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/intimm\/7.8.1243","article-title":"Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4","volume":"7","author":"Rousset","year":"1995","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jneuroim.2024.578423_bb0155","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2013.01.003","article-title":"A review of the use of biological agents for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"326","author":"St\u00fcbgen","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0165","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3389\/fnins.2019.00717","article-title":"Peripheral blood and cerebrospinal fluid cytokine levels in Guillain Barr\u00e9 syndrome: a systematic review and Meta-analysis","volume":"13","author":"Sun","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0170","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0175","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578423_bb0180","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/jnnp-2023-332398","article-title":"Proximity extension assay-based discovery of biomarkers for disease activity in chronic inflammatory demyelinating polyneuropathy","volume":"95","author":"Wieske","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2024.578423_bb0185","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1007\/s10072-020-04949-7","article-title":"Elevated levels of NLRP3 inflammasome in serum of patients with chronic inflammatory demyelinating polyradiculoneuropathy are associated with disease severity","volume":"42","author":"Zhou","year":"2021","journal-title":"Neurol. Sci."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824001425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824001425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T04:02:15Z","timestamp":1724731335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572824001425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":37,"alternative-id":["S0165572824001425"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578423","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomics analysis of immune response-related proteins in Guillain-Barr\u00e9 Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"578423"}}